Soleno Therapeutics (SLNO) Assets Average (2016 - 2019)
Historic Assets Average for Soleno Therapeutics (SLNO) over the last 6 years, with Q3 2019 value amounting to $31.4 million.
- Soleno Therapeutics' Assets Average fell 205.67% to $31.4 million in Q3 2019 from the same period last year, while for Sep 2019 it was $31.4 million, marking a year-over-year decrease of 205.67%. This contributed to the annual value of $41.1 million for FY2018, which is 8429.87% up from last year.
- Latest data reveals that Soleno Therapeutics reported Assets Average of $31.4 million as of Q3 2019, which was down 205.67% from $36.5 million recorded in Q2 2019.
- Soleno Therapeutics' 5-year Assets Average high stood at $41.0 million for Q1 2019, and its period low was $6.9 million during Q3 2016.
- Moreover, its 5-year median value for Assets Average was $28.4 million (2017), whereas its average is $22.5 million.
- As far as peak fluctuations go, Soleno Therapeutics' Assets Average tumbled by 2076.76% in 2016, and later skyrocketed by 37141.92% in 2017.
- Quarter analysis of 5 years shows Soleno Therapeutics' Assets Average stood at $7.7 million in 2015, then dropped by 10.43% to $6.9 million in 2016, then surged by 371.42% to $32.7 million in 2017, then grew by 13.12% to $37.0 million in 2018, then decreased by 15.04% to $31.4 million in 2019.
- Its Assets Average was $31.4 million in Q3 2019, compared to $36.5 million in Q2 2019 and $41.0 million in Q1 2019.